NDC to RxNorm Crosswalk 0078-0909 Kisqali Femara Co-pack

View RxNorm Concepts, RxCUIs, Term Types

RxNorm Crosswalk Information

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The RxNorm crosswalk for NDC code 0078-0909 indicates multiple RxNorm Concept Unique Identifiers known as RxCUIs associated to the product Kisqali Femara Co-pack . The unique RxCUI concepts linked to this product are: 153124, 1873983, 1873989, 1923053, 1923054, 1923055, 1923056, 1923057, 1923058 and 200064. RxCUIs are identifiers that group each chemically distinct drug into a single code regardless of manufacturer or package size. Drugs mapped to the same RxCUI are considered the same drug as having the same ingredients, strengths, and dose forms. The RxNorm mapping may include repeated RxCUI concepts with different descriptions and term types.

RxCUI: 153124

Concept: Femara 2.5 MG Oral Tablet
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: letrozole 2.5 MG Oral Tablet [Femara]
Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
Concept: Femara 2.5 MG Oral Tablet
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1873983

Concept: ribociclib 200 MG Oral Tablet
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: ribociclib 200 MG Oral Tablet
Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form
Concept: ribociclib 200 MG (equivalent to ribociclib succinate 254.4 MG) Oral Tablet
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1873989

Concept: Kisqali 200 MG Oral Tablet
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: ribociclib 200 MG Oral Tablet [Kisqali]
Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
Concept: Kisqali 200 MG (equivalent to ribociclib succinate 254.4 MG) Oral Tablet
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: Kisqali 200 MG Oral Tablet
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1923053

Concept: {28 (letrozole 2.5 MG Oral Tablet) / 21 (ribociclib 200 MG Oral Tablet) } Pack
Term Type (TTY): GPCK - Generic Pack
{# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack
Concept: ribociclib 200 MG / letrozole 2.5 MG Daily Dose Carton
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: letrozole 2.5 MG (28) / ribociclib 200 MG (21) Pack
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1923054

Concept: {28 (letrozole 2.5 MG Oral Tablet [Femara]) / 21 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 200]
Term Type (TTY): BPCK - Brand Name Pack
{# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name]
Concept: Kisqali 200 MG - Femara 2.5 MG Daily Dose Carton
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: Kisqali 200 MG - Femara 2.5 MG Daily Dose Carton
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: Kisqali 200 MG (21) / Femara 2.5 MG (28) Daily Dose Carton
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1923055

Concept: {28 (letrozole 2.5 MG Oral Tablet) / 42 (ribociclib 200 MG Oral Tablet) } Pack
Term Type (TTY): GPCK - Generic Pack
{# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack
Concept: ribociclib 400 MG / letrozole 2.5 MG Daily Dose Carton
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: letrozole 2.5 MG (28) / ribociclib 200 MG (42) Pack
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1923056

Concept: {28 (letrozole 2.5 MG Oral Tablet [Femara]) / 42 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 400]
Term Type (TTY): BPCK - Brand Name Pack
{# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name]
Concept: Kisqali 400 MG - Femara 2.5 MG Daily Dose Carton
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: Kisqali 200 MG (42) / Femara 2.5 MG (28) Daily Dose Carton
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: Kisqali 400 MG - Femara 2.5 MG Daily Dose Carton
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1923057

Concept: {28 (letrozole 2.5 MG Oral Tablet) / 63 (ribociclib 200 MG Oral Tablet) } Pack
Term Type (TTY): GPCK - Generic Pack
{# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack
Concept: ribociclib 600 MG / letrozole 2.5 MG Daily Dose Carton
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: letrozole 2.5 MG (28) / ribociclib 200 MG (63) Pack
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: letrozole 2.5 MG / ribociclib 600 MG Daily Dose Carton
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1923058

Concept: {28 (letrozole 2.5 MG Oral Tablet [Femara]) / 63 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 600]
Term Type (TTY): BPCK - Brand Name Pack
{# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name]
Concept: Kisqali 600 MG - Femara 2.5 MG Daily Dose Carton
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: Kisqali 200 MG (63) / Femara 2.5 MG (28) Daily Dose Carton
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.
Concept: Kisqali 600 MG - Femara 2.5 MG Daily Dose Carton
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 200064

Concept: letrozole 2.5 MG Oral Tablet
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: letrozole 2.5 MG Oral Tablet
Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form


What is RxNorm?

RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.

The goal of RxNorm is to facilitate the efficient exchange of drug information among the computer systems used by hospitals, pharmacies, clinics and other organizations. To achieve this goal RxNorm provides normalized names and unique identifiers for drugs and medicines.

What is an RXCUI?

An RxCUI is machine readable unique identifier that defines the same common concept. Every name and code provided to the National Library of Medicine receives an RXCUI. Drug products that map to the same RxCUI are considered the same drug while drugs that are distinct will have different RxCUIs.

What is a Term Type (TTY)?

Term Types (TTYs) are used to specify the level of complexity of each RxCUI term.

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.